In the News

Dr Ute Berger outlines how ICON is transforming clinical trials in a rapidly shifting landscape in the Executive Interview in Drug Development & Delivery.

Earlene Biggs shares the key elements of an effective strategy to engage with healthcare decision-makers.

In this article, Dinah Knotts speaks about mRNA vaccine technology and what further opportunities it can offer in fighting infectious diseases.

Emily Mitchell contributes to this piece in Clinical Trials Arena on the role of sites in a DCT setting.

Dr. Sandra Eagle outlines how due diligence has evolved from a discrete standalone technical assessment of an asset, to now being an integrated part of the holistic development continuum of an asset.

This news article, published on PM Live, highlights how the partnership will advance trial execution within medical dermatology.

This article, published on Outsourcing Pharma, covers the strategic partnership between LEO Pharma and ICON.

Rose Kidd outlines the role ICON played in the search for vaccines and treatments for Covid-19 in the American Chamber of Commerce Ireland 2023 US-Ireland Business Report.

This news article outlines how the collaboration is expected to provide access to innovative clinical trials as well as help to launch new medicines.

ICON and LEO Pharma have announced a strategic partnership to scale patient-centric and cost-effective clinical trials.